4502 On Other Exchanges
4502 is not on other exchanges.

Executive Profile*

Deborah Dunsire

AgeTotal Calculated CompensationThis person is connected to 175 board members in 5 different organizations across 11 different industries.

See Board Relationships


Dr. Deborah Dunsire, M.D., has been the Chief Executive Officer, President and Director of XTuit Pharmaceuticals, Inc. since March 2017. Dr. Dunsire has been an Independent Director of Alexion Pharmaceuticals, Inc. since January 22, 2018. Dr. Dunsire served as the Chief Executive Officer and President of FORUM Pharmaceuticals Inc. (previously EnVivo Pharmaceuticals) since July 11, 2013. Dr. Dunsire served as the Chief Executive Officer and President at Millennium Pharmaceuticals, ...

Read Full Background


Corporate Headquarters*

12-10, Nihonbashi 2-chome
Osaka, -- 103-8668


Phone: 81 3 3278 2111
Fax: 81 3 3278 2880

Board Members Memberships*

Director At Large
Independent Director
Chief Executive Officer, President and Director
Independent Director


Master's Degree
University of the Witwatersrand
University of the Witwatersrand
Unknown/Other Education
Wits Medical School
Bachelor's Degree
Wits Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.